Tasly Moves Into Global Food Business
This article was originally published in PharmAsia News
Tasly Group, a major traditional Chinese medicine and health care product conglomerate in China, is tapping on cash-strapped Zhoukou Renpeng Cannery to move into the global food industry. Insiders disclosed that Tasly, which will be responsible for manufacturing and sale, has started production by leasing Renpeng's workshops, production equipment and employees. Analysts note that the move stems from Renpeng's international marketing focus which fits Tasly's worldwide export-oriented strategy. The canning firm integrates trading, manufacturing and farming in its business, using advanced technology from Germany and Japan to produce food for export. (Click here for more - Chinese Language)
You may also be interested in...
Lawyer asks US FDA to require another trial before licensing Mesoblast’s stem cell therapy for children with SR-aGVHD; Incyte’s Jakafi is only product approved for the indication.
Hanmi licenses out GLP-1/glucagon receptor dual agonist for NASH to Merck, in a deal worth up to $870m, marking a positive turn for the Korean firm's pipeline after Janssen returned rights last year.
Nomolotus discontinued social media claims that its herbal supplement supports users’ immune systems during the COVID-19 pandemic and customers reviews referencing the virus after the National Advertising Division questioned the statements as misleading.